Unique project – New technology


We are conducting a clinical study on weight and body composition detection using an innovative technology called BioTwin.

Participants will donate biological (blood) samples that will be used to demonstrate the ability of BioTwin's technology to detect people's weight and body composition.

All data collected will be used for research purposes, will be anonymized and secured, and that anonymized biological samples will be retained by BioTwin for an indefinite period. You can request the destruction of your biological sample at any time by contacting BioTwin by email and the company undertakes to proceed with the destruction of the sample within 2 working days of the request.

For more information, please contact us or complete an online form.

I want to apply to this clinical study


For more information, contact us at 581 477-3439 (Québec) or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures


Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.


Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.


Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.


Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.


Step 5 | If you are eligible, you may then begin a clinical study with us.